174 related articles for article (PubMed ID: 10713696)
1. Mammary gland oncogenes as indicators of pathways important in mammary gland development.
Dickson C; Creer A; Fantl V
Oncogene; 2000 Feb; 19(8):1097-101. PubMed ID: 10713696
[TBL] [Abstract][Full Text] [Related]
2. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice.
Kitsberg DI; Leder P
Oncogene; 1996 Dec; 13(12):2507-15. PubMed ID: 9000125
[TBL] [Abstract][Full Text] [Related]
3. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
[TBL] [Abstract][Full Text] [Related]
4. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene.
Robinson GW; Wagner KU; Hennighausen L
Oncogene; 2001 Oct; 20(48):7115-9. PubMed ID: 11704837
[TBL] [Abstract][Full Text] [Related]
5. The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect.
Goetz F; Tzeng YJ; Guhl E; Merker J; Graessmann M; Graessmann A
Oncogene; 2001 Apr; 20(18):2325-32. PubMed ID: 11402328
[TBL] [Abstract][Full Text] [Related]
6. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cyclin D1 and p16(INK4A) is critical for growth arrest during mammary involution.
Gadd M; Pisc C; Branda J; Ionescu-Tiba V; Nikolic Z; Yang C; Wang T; Shackleford GM; Cardiff RD; Schmidt EV
Cancer Res; 2001 Dec; 61(24):8811-9. PubMed ID: 11751403
[TBL] [Abstract][Full Text] [Related]
8. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
Corsino P; Davis B; Law M; Chytil A; Forrester E; Nørgaard P; Teoh N; Law B
Cancer Res; 2007 Apr; 67(7):3135-44. PubMed ID: 17409420
[TBL] [Abstract][Full Text] [Related]
9. HBX causes cyclin D1 overexpression and development of breast cancer in transgenic animals that are heterozygous for p53.
Klein A; Guhl E; Tzeng YJ; Fuhrhop J; Levrero M; Graessmann M; Graessmann A
Oncogene; 2003 May; 22(19):2910-9. PubMed ID: 12771941
[TBL] [Abstract][Full Text] [Related]
10. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.
Toyo-oka K; Bowen TJ; Hirotsune S; Li Z; Jain S; Ota S; Escoubet-Lozach L; Garcia-Bassets I; Lozach J; Rosenfeld MG; Glass CK; Eisenman R; Ren B; Hurlin P; Wynshaw-Boris A
Cancer Res; 2006 Jun; 66(11):5565-73. PubMed ID: 16740691
[TBL] [Abstract][Full Text] [Related]
11. The caM kinase, Pnck, is spatially and temporally regulated during murine mammary gland development and may identify an epithelial cell subtype involved in breast cancer.
Gardner HP; Ha SI; Reynolds C; Chodosh LA
Cancer Res; 2000 Oct; 60(19):5571-7. PubMed ID: 11034105
[TBL] [Abstract][Full Text] [Related]
12. Expression of Brca1 and splice variant Brca1delta11 RNA levels in mouse mammary gland during normal development and tumorigenesis.
Mixon M; Kittrell F; Medina D
Oncogene; 2000 Nov; 19(46):5237-43. PubMed ID: 11077440
[TBL] [Abstract][Full Text] [Related]
13. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors.
Miyoshi K; Rosner A; Nozawa M; Byrd C; Morgan F; Landesman-Bollag E; Xu X; Seldin DC; Schmidt EV; Taketo MM; Robinson GW; Cardiff RD; Hennighausen L
Oncogene; 2002 Aug; 21(36):5548-56. PubMed ID: 12165853
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of cyclin D2 and p27(Kip1) in cyclin D2 transgenic mouse mammary gland during development.
Kong G; Chua SS; Yijun Y; Kittrell F; Moraes RC; Medina D; Said TK
Oncogene; 2002 Oct; 21(47):7214-25. PubMed ID: 12370811
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid signaling is required for proper morphogenesis of mammary gland.
Wang YA; Shen K; Wang Y; Brooks SC
Dev Dyn; 2005 Dec; 234(4):892-9. PubMed ID: 16217742
[TBL] [Abstract][Full Text] [Related]
16. Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis.
Iavnilovitch E; Groner B; Barash I
Mol Cancer Res; 2002 Nov; 1(1):32-47. PubMed ID: 12496367
[TBL] [Abstract][Full Text] [Related]
17. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA involvement in mammary gland development and breast cancer.
Silveri L; Tilly G; Vilotte JL; Le Provost F
Reprod Nutr Dev; 2006; 46(5):549-56. PubMed ID: 17107644
[TBL] [Abstract][Full Text] [Related]
19. The regulation of mammary gland development by hormones, growth factors, and oncogenes.
Rosen JM; Humphreys R; Krnacik S; Juo P; Raught B
Prog Clin Biol Res; 1994; 387():95-111. PubMed ID: 7972261
[No Abstract] [Full Text] [Related]
20. Fibroblast growth factor signalling and cyclin D1 function are necessary for normal mammary gland development during pregnancy. A transgenic mouse approach.
Fantl V; Creer A; Dillon C; Bresnick J; Jackson D; Edwards P; Rosewell I; Dickson C
Adv Exp Med Biol; 2000; 480():1-7. PubMed ID: 10959404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]